News | Contrast Media | October 10, 2017

Guerbet to Participate in French Interventional Radiology Conference

Company will organize pair of symposiums and present mixing and injection system for conventional trans-arterial chemoembolization

Guerbet to Participate in French Interventional Radiology Conference

October 10, 2017 — Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will be held in Paris, France, Oct. 13-16, 2017.

The JFR, a major international gathering for medical imaging players, annually brings together more than 17,000 diagnostic and interventional radiology experts from France and abroad. This year, the JFR, a place for discussion and debate focusing on innovation, research and development, will place emphasis on the theme "Patients and their Radiologists."

Guerbet will present its integrated magnetic resonance imaging (MRI) and scanner offers as well as its digital solutions. For the sixth consecutive year, Guerbet will also be an exhibitor and partner of the "Interventional Radiology Village" where, for the first time, it will present Vectorio, its conventional trans-arterial chemo-embolization (cTACE) mixing and injection device that obtained the CE mark in September 2017. Vectorio encompasses a set of medical devices that are resistant to Lipiodol Ultra Fluide, used for cTACE

Guerbet will also organize two symposiums during the JFR:

  • "Gadolinium deposits in the brain: what is the current situation?" Friday, Oct. 13 — Prof. Fabrice Bonneville (Toulouse University Hospital) will be the moderator and findings will be presented by Prof. Douraied Ben Salem (Brest University Hospital), Dr. Nicolas Menjot De Champfleur (Montpellier University Hospital), Prof. François Cotton (Lyon Public Hospital) and Prof. Isabelle Thomassin (Tenon Public Hospital, Paris).
  • "Guerbet, the present and future in interventional radiology" Saturday, Oct. 14 — Prof. Afshin Gangi (Strasbourg University Hospital) will be the moderator and Prof. Jean-Pierre Pelage (Caen University Hospital), Prof. Patrick Chevallier (Nice University Hospital) and Prof. Romaric Loffroy (Dijon University hospital) will all present their work.

For more information: www.guerbet.com

Related Content

International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...

Photo courtesy of Philips Healthcare

Feature | Radiology Business | May 31, 2019 | By Arjen Radder
Change is a consistent theme in our world today, no matter where you look.
MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...